A polyvalent aptamer system for targeted drug delivery

Biomaterials

Volumn 34, Issue 37, 2013, Pages 9728-9735

  Zhang, Zhiqing ^a,b,c   Ali, M Monsur ^b,c   Eckert, Mark A ^b,c   Kang, Dong Ku ^b,c   Chen, Yih Yang ^b,c   Sender, Leonard S ^d,e   Fruman, David A ^f   Zhao, Weian ^b,c  

^a CHINA UNIVERSITY OF PETROLEUM   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California at Irvine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aptamer; Cancer; Drug delivery; Leukemia; Multivalency; Rolling circle amplification

Indexed keywords

APTAMERS; CANCER; LEUKEMIA; MULTIVALENCY; ROLLING CIRCLE AMPLIFICATIONS;

AMPLIFICATION; BINDING ENERGY; CHEMOTHERAPY; DRUG DELIVERY;

DISEASES;

APTAMER; CIRCULAR DNA; DOXORUBICIN;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; DRUG DELIVERY SYSTEM; DRUG TARGETING; GENE AMPLIFICATION; HUMAN; INTERNALIZATION; LEUKEMIA CELL; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; ROLLING CIRCLE AMPLIFICATION;

APTAMER; CANCER; DRUG DELIVERY; LEUKEMIA; MULTIVALENCY; ROLLING CIRCLE AMPLIFICATION;

ANTIBIOTICS, ANTINEOPLASTIC; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LEUKEMIA;

EID: 84884813270     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.079     Document Type: Article

References (46)

1. Mallikaratchy P.R., Ruggiero A., Gardner J.R., Kuryavyi V., Maguire W.F., Heaney M.L., et al. Amultivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia. Nucleic Acids Res 2011, 39:2458-2469.
2. Yang L., Meng L., Zhang X., Chen Y., Zhu G., Liu H., et al. Engineering polymeric aptamers for selective cytotoxicity. JAm Chem Soc 2011, 133:13380-13386.
3. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
4. Liu Z., Duan J.H., Song Y.M., Ma J., Wang F.D., Lu X., et al. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells invitro. JTransl Med 2012, 10:148-157.
5. Xu W., Siddiqui I.A., Nihal M., Pilla S., Rosenthal K., Mukhtar H., et al. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials 2013, 34:5244-5253.
6. Hubbell J.A., Chilkoti A. Nanomaterials for drug delivery. Science 2012, 337:303-305.
7. Keefe A.D., Pai S., Ellington A. Aptamers as therapeutics. Nat Rev Drug Discov 2010, 9:537-550.
8. Bagalkot V., Farokhzad O.C., Langer R., Jon S. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed 2006, 45:8149-8152.
9. Huang Y.F., Shangguan D., Liu H., Phillips J.A., Zhang X., Chen Y., et al. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem 2009, 10:862-868.
10. Ray P., White R.R. Aptamers for targeted drug delivery. Pharmaceuticals 2010, 3:1761-1778.
11. Thiel K. Oligo oligarchy-the surprisingly small world of aptamers. Nat Biotechnol 2004, 22:649-651.
12. Mammen M., Choi S.K., Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 1998, 37:2754-2794.
13. Kolonko E.M., Kiessling L.L. Apolymeric domain that promotes cellular internalization. JAm Chem Soc 2008, 130:5626-5627.
14. Kiessling L.L., Gestwichi J.E., Strong L.E. Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr Opin Chem Biol 2000, 4:696-703.
15. Kibria G., Hatakeyama H., Ohga N., Hida K., Harashima H. The effect of liposomal size on the targeted delivery of doxorubicin to integrin αvβ3-expressing tumor endothelial cells. Biomaterials 2013, 34:5617-5627.
16. Gorityala B.K., Lu Z., Leow M.L., Ma J., Liu X.W. Design of a "turn-off/turn-on" biosensor: understanding carbohydrate-lectin interactions for use in noncovalent drug delivery. JAm Chem Soc 2012, 134:15229-15232.
17. Tong G.J., Hsiao S.C., Carrico Z.M., Francis M.B. Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. JAm Chem Soc 2009, 131:11174-11178.
18. Zhao W., Cui C.H., Bose S., Guo D., Shen C., Wong W.P., et al. Bioinspired multivalent DNA network for capture and release of cells. Proc Natl Acad Sci U S A 2012, 109:19626-19631.
19. Zhao W., Ali M.M., Brook M.A., Li Y. Rolling circle amplification: applications in nanotechnology and biodetection with functional nucleic acids. Angew Chem Int Ed 2008, 47:6330-6337.
20. Tang L., Liu Y., Ali M.M., Kang D.K., Zhao W., Li J. Colorimetric and ultrasensitive bioassay based on a dual-amplification system using aptamer and DNAzyme. Anal Chem 2012, 84:4711-4717.
21. Hamblin G.D., Carneiro K.M.M., Fakhoury J.F., Bujold K.E., Sleiman H.F. Rolling circle amplification-templated DNA nanotubes show increased stability and cell penetration ability. JAm Chem Soc 2012, 134:2888-2891.
22. Li Z., Wei B., Nangreave J., Lin C., Liu Y., Mi Y., et al. Areplicable tetrahedral nanostructure self-assembled from a single DNA strand. JAm Chem Soc 2009, 131:13093-13098.
23. Amiram M., Quiroz F.G., Callahan D.J., Chilkoti A. Ahighly parallel method for synthesizing DNA repeats enables the discovery of 'smart' protein polymers. Nat Mater 2011, 10:141-148.
24. Larsson C., Koch J., Nygren A., Janssen G., Raap A.K., Landegren U., et al. In situ genotyping individual DNA molecules by target-primed rolling-circle amplification of padlock probes. Nat Methods 2004, 1:227-232.
25. Lee J.B., Peng S., Yang D., Roh Y.H., Funabashi H., Park N., et al. Amechanical metamaterial made from a DNA hydrogel. Nat Nanotechnol 2012, 7:816-820.
26. Tian Y., He Y., Mao C. Cascade signal amplification for DNA detection. Chembiochem 2006, 7:1862-1864.
27. Cheglakov Z., Weizmann Y., Braunschweig A.B., Wilner O.I., Willner I. Increasing the complexity of periodic protein nanostructures by the rolling circle amplified synthesis of aptamers. Angew Chem Int Ed 2008, 47:126-130.
28. Cheglakov Z., Weizmann Y., Basnar B., Willner I. Diagnosing viruses by the rolling circle amplified synthesis of DNAzymes. Org Biomol Chem 2007, 5:223-225.
29. Zhu G., Zheng J., Song E., Donovan M., Zhang K., Liu C., et al. Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci U S A 2013, 110:7998-8003.
30. Shangguan D., Li Y., Tang Z., Cao Z.C., Chen H.W., Mallikaratchy P., et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 2006, 103:11838-11843.
31. Shangguan D., Cao Z., Meng L., Mallikaratchy P., Sefah K., Wang H., et al. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. JProteome Res 2008, 7:2133-2139.
32. Zhao W., Brook M.A., Li Y. Periodic assembly of nanospecies on repetitive DNA sequences generated on gold nanoparticles by rolling circle amplification. Methods Mol Biol 2008, 474:79-90.
33. Bagalkot V., Zhang L., Levy-Nissenbaum E., Jon S., Kantoff P.W., Langer R., et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 2007, 7:3065-3070.
34. Xiao Z., Levy-Nissenbaum E., Alexis F., Luptak A., Teply B.A., Chan J.M., et al. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano 2012, 6:696-704.
35. Liu X., Yan H., Liu Y., Chang Y. Targeted cell-cell interactions by DNA nanoscaffold-templated multivalent bispecific aptamers. Small 2011, 7:1673-1682.
36. Min K., Jo H., Song K., Cho M., Chun Y.S., Jon S., et al. Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers. Biomaterials 2011, 32:2124-2132.
37. Liu J., Cao Z., Lu Y. Functional nucleic acid sensors. Chem Rev 2009, 109:1948-1998.
38. Zhang H., Li F., Dever B., Li X.F., Chris Le X. DNA-mediated homogeneous binding assays for nucleic acids and proteins. Chem Rev 2013, 113:2812-2841.
39. Douglas S.M., Bachelet I., Church G.M. Alogic-gated nanorobot for targeted transport of molecular payloads. Science 2012, 335:831-834.
40. Zhu G., Zhang S., Song E., Zheng J., Hu R., Fang X., et al. Building fluorescent DNA nanodevices on target living cell surfaces. Angew Chem Int Ed 2013, 52:5490-5496.
41. Cheng Z., Zaki A.A., Hui J.Z., Muzykantov V.R., Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 2012, 338:903-910.
42. Wang K., You M., Chen Y., Han D., Zhu Z., Huang J., et al. Self-assembly of a bifunctional DNA carrier for drug delivery. Angew Chem Int Ed 2011, 50:6098-6101.
43. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
44. Kim E., Jung Y., Choi H., Yang J., Suh J.S., Huh Y.M., et al. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex. Biomaterials 2010, 31:4592-4599.
45. Mi J., Zhang X., Rabbani Z.N., Liu Y., Reddy S.K., Su Z., et al. RNA aptamer-targeted inhibition of NF-κB suppresses non-small cell lung cancer resistance to doxorubicin. Mol Ther 2007, 16:66-73.
46. Cerchia L., Esposito C.L., Camorani S., Rienzo A., Stasio L., Insabato L., et al. Targeting Axl with an high-affinity inhibitory aptamer. Mol Ther 2012, 20:2291-2303.